The number of Americans with a history of cancer is projected to be 18.1 million in 2020. The increase in people living with cancer and the introduction of new therapies are associated with a rise in cancer costs. This report identifies trends in the overall and component costs of cancer care, creates comparisons to cost trends in the non-cancer population, and identifies several drivers influencing the rising cost of cancer care.
This report was commissioned by the Community Oncology Alliance.
Article
Given the greater flexibility and lower costs provided under ARPA’s provisions, plan sponsors should seize this moment to reevaluate and optimize their risk management strategies by considering the whole picture.
Cost drivers of cancer care: A retrospective analysis of Medicare and commercially insured population claim data 2004-2014
This report identifies trends in the overall and component costs of cancer care, creates comparisons to cost trends in the non-cancer population, and identifies several drivers influencing the rising cost of cancer care.